Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT05184335 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | Clinical Trial |
| Target Enrollment | 690 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Reviva Pharmaceuticals |
| Last Updated on CT.gov | December 19, 2024 (Dec 19, 2024) |
As of March 2, 2026: Clinical trial NCT05184335 is currently recruiting participants. This clinical trial study for schizophrenia is actively seeking new participants at 18 locations across the United States. The study is sponsored by Reviva Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05184335 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05184335 was last updated Dec 19, 2024 (December 19, 2024). HelloStudys verifies this status automatically.